Epidemiology of respiratory syncytial virus in a German hospital before, during and after the COVID-19 pandemic – a real world monocentric analysis over ten years - Scorecard - MDSpire
Advertisement
Epidemiology of respiratory syncytial virus in a German hospital before, during and after the COVID-19 pandemic – a real world monocentric analysis over ten years
Clinical Scorecard: Analysis of Respiratory Syncytial Virus Epidemiology in a German Pediatric Hospital Before, During, and After the COVID-19 Pandemic: A Decadal Monocentric Study
At a Glance
Category
Detail
Condition
Respiratory Syncytial Virus (RSV) Infection
Key Mechanisms
Seasonal patterns influenced by COVID-19 pandemic interventions
Target Population
Pediatric patients, primarily infants under 2 years
Care Setting
Pediatric hospital
Key Highlights
RSV seasons shifted significantly during and after the COVID-19 pandemic.
Increased hospitalization rates and severity observed in the post-pandemic season.
Bacterial superinfection and antibiotic treatment were more frequent post-pandemic.
Guideline-Based Recommendations
Diagnosis
Laboratory confirmation of RSV infection in patients with bronchitis, bronchiolitis, or pneumonia.
Management
Consideration of prophylactic interventions such as nirsevimab and RSVpreF vaccine.
Monitoring & Follow-up
Ongoing surveillance of RSV patterns to inform healthcare resource allocation.
Risks
Increased risk of severe disease in infants and potential for bacterial superinfection.
Patient & Prescribing Data
Children under 12 years, primarily those under 2 years.
Nirsevimab shows 93% effectiveness against RSV-associated hospitalization.
Clinical Best Practices
Target prophylactic measures towards high-risk groups such as infants and pregnant women.
Timely intervention based on seasonal RSV patterns.
